Dr. David Cohen

A protein called Them1 prevents fat burning in cells by blocking access to the fuel source, according to preclinical research by Weill Cornell Medicine, NewYork-Presbyterian and Harvard Medical School/Beth Israel Deaconess Medical Center investigators.

Two distinguished Weill Cornell Medicine physician-scientists have been elected to the prestigious Association of American Physicians (AAP). 

Gut microbes influence blood glucose levels by acting directly on the liver, not by regulating the energy expenditure of specialized fat tissues, which use glucose as fuel to create heat.

Dr. Randy Longman, an accomplished physician-scientist, has been appointed director of the Jill Roberts Center for Inflammatory Bowel Disease at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.

A key enzyme in liver cells may provide physicians with a new strategy for treating a liver disease often linked to overeating, obesity and diabetes.

Dr. Robert Burakoff has been named vice chair for ambulatory services for the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and site chief for the Division of Gastroenterology and Hepatology at NewYork-Presbyterian Lower Manhattan Hospital and Weill Cornell Medicine.

Dr. David Carr-Locke has been recruited as clinical director of the Center for Advanced Digestive Care at NewYork-Presbyterian/Weill Cornell Medical Center.